Polymorphic Expression of UDP-Glucuronosyltransferase UGTlA Gene in Human Colorectal Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wang, Min ^a   Sun, De Feng ^b   Wang, Shuai ^a   Qing, Ying ^a   Chen, Shuo ^a   Wu, Dong ^c   Lin, Ying Min ^a   Luo, Ji Zhuang ^d   Li, Yan Qing ^a  

^a Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

^b Shandong Medical School   (China)

^c SHANDONG UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A10; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A5; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 1A9; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; DOWN REGULATION; EXON; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENOTYPE; GLUCURONIDATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; UPREGULATION;

AGED; ALLELES; BASE SEQUENCE; COLORECTAL NEOPLASMS; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; RNA ISOFORMS; RNA, MESSENGER;

EID: 84874526847     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057045     Document Type: Article

References (45)

1. Wan DS, (2009) Epidemiologic trend of and strategies for colorectal cancer. Ai Zheng 28: 897-902.
2. Aiello M, Vella N, Cannavo C, Scalisi A, Spandidos DA, et al. (2011) Role of genetic polymorphisms and mutations in colorectal cancer therapy. Mol Med Report 2: 203-208.
3. Karl Walter Bock, (2012) Human UDP-glucuronosyltransferases:Feedback loops between substrates and ligands of their transcription factors. Biochem Pharmacol 8: 1000-1006.
4. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, et al. (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15: 677-685.
5. Myllynen P, Pasanen M, Pelkonen O, (2005) Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta 26: 361-371.
6. Syme MR, Paxton JW, Keelan JA, (2004) Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 43: 487-514.
7. Myllynen P, Pasanen M, Vahakangas K, (2007) The fate and effects of xenobiotics in human placenta. Expert Opin Drug Metab Toxicol 3: 331-346.
8. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T, (2008) Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36: 1461-1464.
9. http://www.ugtalleles.ulaval.ca, access date: 11 June 2009.
10. Gong QH, Cho JW, Huang T, Potter C, Gholami N, et al. (2001) Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11: 357-368.
11. Strassburg CP, Oldhafer K, Manns MP, Tukey RH, (1997) Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol 52: 212-220.
12. Strassburg CP, Manns MP, Tukey RH, (1998) Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 273: 8719-8726.
13. Dura P, Salomon J, Te Morsche RH, Roelofs HM, Kristinsson JQ, et al. (2012) High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk. Int J Oncol 6: 1789-1796.
14. Cheng Z, Radominska-Pandya A, Tephly TR, (1998) Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8. Arch Biochem Biophys 356: 301-305.
15. Maitland ML, Grimsley C, Kuttab-Boulos H, Witonsky D, Kasza KE, et al. (2006) Comparative genomics analysis of human sequence variation in the UGT1A gene cluster. Pharmacogenomics J 6: 52-62.
16. Thomas SS, Li SS, Lampe JW, Potter JD, Bigler J, (2006) Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus. Hum Mutat 27: 717.
17. Sai K, Seaki M, Saito Y, Katori N, Jinno H, et al. (2004) UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther 75: 501-515.
18. Farheen S, Sengupta S, Santra A, Pal S, (2006) Dhali (2006) Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene. World J Gastroenterol 12: 2269-2275.
19. Caillier B, Lepine J, Tojcic J, Menard V, Perusse L, et al. (2007) A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3. Pharmacogenet Genomics 17: 481-495.
20. Iwai M, Maruo Y, Ito M, Yamamoto K, Sato H, et al. (2004) Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. J Hum Genet 49: 123-128.
21. Ehmer U, Vogel A, Schutte JK, Krone B, Manns MP, et al. (2004) Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39: 970-977.
22. Saeki M, Saito Y, Jinno H, Sai K, Hachisuka K, et al. (2005) Genetic variations and haplotypes of UGT1A4 in a Japanese population. Drug Metab Pharmacokinet 20: 144-151.
23. Lampe JW, Bigler J, Horner NK, Potter JD, (1999) UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 9: 341-349.
24. Osawa K, Nakarai C, Akiyama M, Hashimoto R, Tsutou A, et al. (2012) Association between polymorphisms in UDP-glucuronosyltransferase 1A6 and 1A7 and colorectal cancer risk. Asican Pac J cancer Prev 5: 2311-2314.
25. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE, (2000) Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10: 629-644.
26. Saeki M, Saito Y, Jinno H, Ozawa S, Kurose K, et al. (2006) Haplotype structures of the UGT1A gene complex in a Japanese population. Pharmacogenomics J 6: 63-75.
27. Huang YH, Galijatovic A, Nquyen N, Geske D, Beaton D, et al. (2002) Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 12: 287-297.
28. Mojarrabi B, Mackenzie PI, (1998) Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon. Biochem Biophys Res Commun 247: 704-709.
29. Bernard O, Guillemette C, (2004) The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Dispos 32: 775-778.
30. Tang KS, Chiu HF, Chen HH, Eng HL, Tsai CJ, et al. (2005) Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes. World J Gastroenterol 11: 3250-3254.
31. Tseng CS, Tang KS, Lo HW, Ker CG, Teng HC, et al. (2005) UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol 100: 1758-1763.
32. Stucker I, Loriot MA, N'koutchou G, Cenee S, Bodin L, et al. (2007) UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers? BMC Cancer 7: 214.
33. Wang Y, Kato N, Hoshida Y, Otsuka M, Taniguchi H, et al. (2004) UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infection. Clin Cancer Res 10: 2441-2446.
34. Kong SY, Ki CS, Yoo BC, Kim JW, (2008) UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers. Cancer Sci 99: 340-344.
35. Min Wang, Yanqing Li, Defeng Sun, Zhimin Wang, Xiaoqun Xu, et al. (2005) Polymorphic expression of UDP-glucuronosyltransferase UGTlA gene locus in human colorectal epithelium. Chinese Journal of Pathophysiology 21(7): 1315-1320.
36. Vasen HF, Watson P, Mecklin JP, Lynch HT, (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116: 1453-1456.
37. Butler M, Duguay Y, Millikan RC, Sinha R, Gagne JF, et al. (2005) Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 14: 1626-1632.
38. Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP, (2002) Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50: 851-856.
39. Chen K, Jin M, Zhu Y, Jiang Q, (2006) Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population. J Gastroenterol Hepatol 21: 1036-1041.
40. Wang Min, Li Yanqing, Chen Jian, (2006) Polymorphic gene regulation of UDP-glucuronosyltransferase 1A in human eolorectal epithelium and liver. Chinese Journal of Digestion 26(2): 96-99.
41. Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, et al. (2006) Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype. Hepatology 44: 1324-1332.
42. Lankisch TO, Schulz C, Zwingers T, Erichsen TJ, Manns MP, et al. (2008) Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. Cancer Epidemiol Biomarkers Prev 17: 695-701.
43. Udomuksorn W, Elliot DJ, Lewis BC, Mackenzie PI, Yoovathaworn K, et al. (2007) Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Pharmacogenet Genomics 17: 1017-1029.
44. Ishii Y, Nurrochmad A, Yamada H, (2010) Modulation of UDP-glucuronosyltransferase activity by endogenous compounds. Drug Metab Pharmacokinet 25: 134-148.
45. Bock KW, (2010) Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol 80: 771-777.